On November 29th, Imperial inaugurated the International Phenome Centre Network (IPCN), at the WISH conference in Doha. Building on the best-practices established at the MRC-NIHR National Phenome Centre, the IPCN will promote global harmonisation in the field of metabolic phenotyping, and using the data sets generated, conduct research to inform global public health policies and the development of new therapies.
Dame Sally Davies, the UK’s Chief Medical Officer stated:
Phenomic research really is one of the next medical frontiers which can advance our understanding of a whole raft of diseases and conditions. The way we treat autism, cancers, mental health, stroke, obesity, metabolic diseases and type 2 diabetes could all be revolutionised by research in this area. It is also really good for work to cross international boundaries to find ways of tackling the biggest global public health challenges facing us today faster.
Congratulations to Professor Ian Wilson who was awarded the Martin Medal, from the Chromatographic Society which recognises scientists who have made outstanding contributions to the advancement of separation science. Professor Wilson received the medal from Dr Tony Edge of the Chromatographic Society in the closing ceremony of the 31st International Symposium on Chromatography (ISC), which was held from the 28th August to the 1st of September 2016, at the University of Cork, Ireland.
The Nobel Prize in Chemistry 1952 was awarded jointly to Archer John Porter Martin and Richard Laurence Millington Synge “for their invention of partition chromatography”. In 1978 Prof Martin gave permission for the Chromatographic Society (Society currently celebrating its 60th Anniversary Year) to associate his name with the Martin Medal.
Members of the All Party Parliamentary Group (APPG) for Ovarian Cancer including Sharon Hodgson MP (Chair) and Mark Durkan MP visited the Imperial Ovarian Cancer Action Research Centre (OCARC) last week, together with representatives from Ovarian Cancer Action, to learn about some of the ovarian research being carried out at Imperial. After some good discussion around ovarian cancer screening, genetic testing and strategies for early detection and diagnosis, the group had a tour of the OCARC labs and discussion with some of the scientists.